We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
(-3%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.75%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$60.7M |
| 2 |
Analog Devices
ADI
|
+$46.1M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$37.3M |
| 4 |
Match Group
MTCH
|
+$28.2M |
| 5 |
GXO Logistics
GXO
|
+$19.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$89.3M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$78.9M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$77.4M |
| 4 |
Apple
AAPL
|
+$77M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$70.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.91% |
| 2 | Financials | 14.2% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 12.09% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
Camden National
CAC
$976M
| $1.07M | ﹤0.01% |
22,311
+700
| +3% | +$32.3K |
|
|
TEN
2202
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $1.07M | ﹤0.01% |
74,680
+841
| +1% | +$13.6K |
|
|
CPLG
2203
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
| $1.07M | ﹤0.01% |
68,768
+2,099
| +3% | +$29K |
|
|
DM
2204
DELISTED
Desktop Metal, Inc.
DM
| $1.06M | ﹤0.01% |
14,808
+5,749
| +63% | +$499K |
|
|
KYNB
2205
Kyntra Bio
KYNB
$29.4M
| $1.06M | ﹤0.01% |
4,150
-111
| -3% | -$39.3K |
|
|
YMAB
2206
DELISTED
Y-mAbs Therapeutics
YMAB
| $1.06M | ﹤0.01% |
37,022
+2,001
| +6% | +$63.1K |
|
|
AVID
2207
DELISTED
Avid Technology Inc
AVID
| $1.05M | ﹤0.01% |
36,463
+1,806
| +5% | +$55.8K |
|
2208
Argan
AGX
$8.37B
| $1.05M | ﹤0.01% |
24,079
+608
| +3% | +$27.5K |
|
|
RNAM
2209
DELISTED
Avidity Biosciences
RNAM
| $1.05M | ﹤0.01% |
42,624
+5,113
| +14% | +$111K |
|
|
FBMS
2210
DELISTED
The First Bancshares, Inc.
FBMS
| $1.05M | ﹤0.01% |
27,070
+950
| +4% | +$36.7K |
|
|
RUBY
2211
DELISTED
Rubius Therapeutics, Inc
RUBY
| $1.05M | ﹤0.01% |
58,683
+1,652
| +3% | +$35.9K |
|
|
DNMR
2212
DELISTED
Danimer Scientific, Inc.
DNMR
| $1.04M | ﹤0.01% |
1,599
+41
| +3% | +$30.1K |
|
2213
Sutro Biopharma
STRO
$421M
| $1.04M | ﹤0.01% |
5,524
+203
| +4% | +$38.6K |
|
2214
Telos
TLS
$358M
| $1.04M | ﹤0.01% |
36,675
+21,230
| +137% | +$639K |
|
2215
Motorcar Parts of America
MPAA
$258M
| $1.04M | ﹤0.01% |
53,321
-6,951
| -12% | -$145K |
|
2216
Energy Fuels
UUUU
$3.53B
| $1.04M | ﹤0.01% |
147,921
+5,821
| +4% | +$33.2K |
|
|
XENT
2217
DELISTED
Intersect ENT, Inc
XENT
| $1.03M | ﹤0.01% |
37,904
+250
| +0.7% | +$6.18K |
|
|
FMTX
2218
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $1.03M | ﹤0.01% |
44,391
+1,875
| +4% | +$44.3K |
|
2219
ANI Pharmaceuticals
ANIP
$1.78B
| $1.02M | ﹤0.01% |
31,189
-3,257
| -9% | -$101K |
|
|
VXRT
2220
DELISTED
Vaxart
VXRT
| $1.02M | ﹤0.01% |
128,589
+1,483
| +1% | +$12.2K |
|
|
XOG
2221
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
| $1.02M | ﹤0.01% |
18,009
+750
| +4% | +$35.9K |
|
2222
Dorian LPG
LPG
$1.96B
| $1.01M | ﹤0.01% |
81,388
-10,019
| -11% | -$125K |
|
2223
Nicolet Bankshares
NIC
$3.62B
| $1M | ﹤0.01% |
13,506
+1,049
| +8% | +$76.6K |
|
2224
Omeros
OMER
$959M
| $998K | ﹤0.01% |
72,356
-2,490
| -3% | -$37.3K |
|
|
APTS
2225
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $995K | ﹤0.01% |
81,358
+1,944
| +2% | +$22K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2021 Portfolio in Review
As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
- RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
- RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
- RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
- RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
- RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
- RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.
Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.